Affiliation:
1. Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece
2. Veterinary Faculty, University of Thessaly, 43100 Karditsa, Greece
Abstract
To date, three carbapenem resistance mechanisms have been identified: carbapenemase released from the pathogen, changes in the expression of the outer membrane OprD porin, and overexpression of the efflux pump MexAB-OprM. Twelve carbapenemase-negative carbapenem-resistant Pseudomonas aeruginosa strains, isolated from patients hospitalized at the University Hospital of Larissa, Central Greece, during 2023, which belonged to various sequence types (STs), were selected and were studied focusing on the characterization of their β-lactamases, on changes to OprD and its regulator MexT proteins, and on alterations to the MexAB-OprM regulator proteins encoded by the mexR, nalC, and nalD genes. Whole genome sequencing analysis revealed the presence of β-lactamase encoding genes, with blaPAO present in all isolates. Additionally, seven different genes of the oxacillinase family (blaOXA-35, blaOXA-50, blaOXA-395, blaOXA-396, blaOXA-486, blaOXA-488, blaOXA-494) were identified, with each strain harboring one to three of these. Regarding the OprD, five strains had truncated structures, at Loop 2, Loop 3, Loop 4, and Loop 9, while the remaining strains carried previously reported amino acid changes. Further, an additional strain had a truncated MexR; whereas, two other strains had totally modified NalC sequences. The active form of MexT, responsible for the downregulation of OprD production, as the intact sequence of the NalD protein, was found in all the strains studied. It is concluded that the truncated OprD, MexR, and NalC proteins, detected in eight strains, probably led to inactive proteins, contributing to carbapenem resistance. However, four strains carried known modifications in OprD, MexR, and NalC, as previously reported in both susceptible and resistant strains, a finding that indicates the complexity of carbapenem resistance in P. aeruginosa.
Reference35 articles.
1. Antibiotic resistance in Pseudomonas aeruginosa—Mechanisms, epidemiology and evolution;Botelho;Drug Resist. Updat.,2019
2. World Health Organization (2024, February 27). WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed, 27 February 2017, Available online: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.
3. The intriguing carbapenemases of Pseudomonas aeruginosa: Current status, genetic profile, and global epidemiology;Halat;Yale J. Biol. Med.,2022
4. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital;Hammami;Pathol. Biol.,2009
5. Structure, function and regulation of Pseudomonas aeruginosa porins;Chevalier;FEMS Microbiol. Rev.,2017